Assessment of Autonomic Co-regulation Between Newborn and Parent During Kangaroo Care Sessions in Neonatal Intensive Care Units (Co-PAP)

Mother-infant separation, as a result of hospitalization, leads to stress and anxiety for both parent and infant, lowers feelings of maternal competency and corrupts bonding process.

Kangaroo Care (KC), is as a widespread procedure in which the naked newborn is placed on the parent's bare chest. KC is known to enhance neonatal outcome by improving temperature regulation, cardiorespiratory stability or psychomotor development. It also promotes mother-infant interactions and enhances parental psychological well-being.

Heart rate variability (HRV) analysis is a non-invasive tool able to consider autonomic nervous system activity. Previous studies have shown that pleasant feelings are associated with an increase of high frequencies variations index (HFnu index) reflecting a prevalence of parasympathetic activity. This one can be assess by a new monitor called NIPΣ (Neonatal index of parasympathetic activity) in newborns and ANI (Analgesic nociception index) in adults can provide a comfort index by quantifying the parasympathetic tone.

The investigators hypothesize that kangaroo care could induce an autonomic co-regulation between newborn and parent by increasing parasympathetic activity.

The study will involve 40 preterm or term newborns and their parent, performing a one hour kangaroo care session in intensive unit and neonatal intensive care unit from hospital of Saint-Etienne (France).

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-Étienne, France, 42055
        • CHU de Saint Etienne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 3 months (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria for the newborn :

  • Neonates over 28 weeks of gestational age, under 3 months, hospitalized in neonatal intensive care units of the university hospital of Saint-Etienne (France),
  • performing a one hour (or more) kangaroo care session with his parent.

Inclusion Criteria for the parent (father or mother) :

- To be a parent of a child eligible for the research protocol,

Exclusion Criteria for the newborn :

  • Newborn sedated
  • Newborn with a treatment known to alter the sympathetic or parasympathetic activity of the autonomic nervous system.
  • Associated and severe brain pathology
  • Anoxo-ischemic encephalopathy
  • Unbalanced congenital heart disease,

Exclusion Criteria for the parents :

  • Parent with a treatment known to alter the sympathetic or parasympathetic activity of the autonomic nervous system.
  • Heart surgery or cardiac pathology
  • History of psychiatric pathology

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: newborn is above 28 weeks of gestational age
40 parent-newborn duos in which the newborn is above 28 weeks of gestational age and less than 3 months of life and hospitalized in neonatal intensive care units of our university hospital (Saint-Etienne - France)
The ECG signal, respiration rate, SpO2 and NIPΣ or ANI are recorded simultaneously on a computer with a capture card. The other indices of HRV will be analyzed offline: SDNN (standard deviation of all NN intervals), pNN30 (NN30 count divided by the total number of all NN intervals), pNN50 (NN50 count divided by the total number of all NN intervals), RMSSD (quadratic mean of successive R-R intervals), SD1 (standard deviation), SD2 (standard deviation), LF (low frequencies), HF (high frequencies), VLF (very low frequencies), SDANN (standard deviation of the averages of NN intervals in all 5 min segments of the entire recording), ratio LF/ HF, Ptot, Poincaré plot (plot points corresponding to each R-R space of a record).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change form baseline high frequency index (HFnu) of variability RR short-term heart rate (HRV) in the frequency domain, from the parent and the child at 1 hour
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of the NIPE index of comfort and discomfort (Mdoloris Medical Systems ®) for the newborn
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.

NIPΣ (neonatal index of parasympathetic activity) : evaluate the comfort of the newborn during the skin-to-skin session.

NIPΣ is physiologically above 60%. The threshold of discomfort in the newborn would correspond to a value <60.

Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Evaluation of the ANI index of comfort and discomfort (Mdoloris Medical Systems ®) for the parent.
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.

ANI (analgesia nociception index) : evaluate an index of continuous analgesia during the skin-to-skin session.

ANI is physiologically above 60%. The threshold of discomfort in the newborn would correspond to a value <60.

Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
gestational age
Time Frame: at the inclusion
at the inclusion
Ptot (indices of variability of heart rate) for the parent
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Ptot (indices of variability of heart rate) for the newborn
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
VLF (indices of variability of heart rate) for the parent
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
VLF (indices of variability of heart rate) for the newborn
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
LF (indices of variability of heart rate) for the parent
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
LF (indices of variability of heart rate) for the newborn
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
HF (indices of variability of heart rate) for the parent
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
HF (indices of variability of heart rate) for the newborn
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
ratio LF/HF (indices of variability of heart rate) for the parent
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
ratio LF/HF (indices of variability of heart rate) for the newborn
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
SDNN (indices of variability of heart rate) for the parent
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
SDNN (indices of variability of heart rate) for the newborn
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
SDANN (indices of variability of heart rate) for the parent
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
SDANN (indices of variability of heart rate) for the newborn
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
pNN30 and pNN50 (indices of variability of heart rate) for the parent
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
pNN30 and pNN50 (indices of variability of heart rate) for the newborn
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
RMSSD (indices of variability of heart rate) for the parent
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
RMSSD (indices of variability of heart rate) for the newborn
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
SD1 and SD2 (indices of variability of heart rate) for the parent
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
SD1 and SD2 (indices of variability of heart rate) for the newborn
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Poincaré-plot index (indices of variability of heart rate) for the parent
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Poincaré-plot index (indices of variability of heart rate) for the newborn
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
fractal index (indices of variability of heart rate) for the parent
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
fractal index (indices of variability of heart rate) for the newborn
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
entropy index (indices of variability of heart rate) for the parent
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
entropy index (indices of variability of heart rate) for the newborn
Time Frame: Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.
Measured during the ECG recording
Minutes 0 (early skin to skin), 10, 20, 30, 40, 50 and 60.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hugues PATURAL, MD PhD, CHU de Saint Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 19, 2018

Primary Completion (Actual)

October 25, 2018

Study Completion (Actual)

October 25, 2018

Study Registration Dates

First Submitted

September 24, 2018

First Submitted That Met QC Criteria

September 28, 2018

First Posted (Actual)

October 1, 2018

Study Record Updates

Last Update Posted (Actual)

October 31, 2018

Last Update Submitted That Met QC Criteria

October 30, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 18CH048
  • 2018-A00765-50 (Other Identifier: ANSM)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Newborn

Clinical Trials on Evaluation of Autonomic nervous system indices

Subscribe